DropGenie is a Montreal- and Boston-based biotechnology company building a digital microfluidics platform that miniaturizes and automates non-viral gene-editing workflows. Its chip-based cartridge manipulates tiny droplets to deliver editing machinery directly into primary patient cells, enabling low-volume, high-throughput cell engineering for cell therapy, functional genomics, and AI-driven discovery. The technology aims to generate large volumes of standardized gene-editing data for pharmaceutical, biotech, and research customers.
1
Round
1
Industry
5
Tags
Oct 26, 2026
Latest raise
Funding activity · 1 round
Oct 26, 2026
$5M
Seed
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
